An observational study was conducted in many countries to collect data regarding the current treatment practices and their outcomes in a patient with weak immunity who was admitted to the intensive care unit with severe difficulty in breathing for improvement in future treatment practices.
- Conditions
- Health Condition 1: J960- Acute respiratory failureHealth Condition 2: D849- Immunodeficiency, unspecified
- Registration Number
- CTRI/2024/01/061901
- Lead Sponsor
- Groupe de Recherche respiratoire en Réanimation Onco Hématologique
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1 adult patients
2 admitted to the ICU between 1 Jan 2017 to 31 Dec 2022
3. with acute respiratory failure oxygen dependance more than 6 liter per min to achieve SPO2 more than 92 percentage and or respiratory rate more than 30 per minute and or labored breathing and or the need for non invasive or invasive mechanical ventilation or high flow nasal cannula
4 with a known immunodepression hematological malignancy including autologous and allogeneic stem cell transplant, solid tumor requiring treatments over the last five years, solid organ transplant, immunosuppressive drugs for auto-immune or auto inflammatory disease and primary immunodeficeincy
1. Patients with isolated HIV infection are not eligible for this study
2. Patients already included in the cohort
3. Patient refuse for consent and data collection
4. Patients deprived of liberty under guardianship or curatorship
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.